The user had asked for a simple PowerShell script to remove Python pycache folders. Instead, the script ended up deleting the contents of the user’s F: drive, including project files and Docker data.

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...

A contracted hunter captured the second-heaviest Burmese python ever recorded in Florida, weighing 202 pounds. Invasive Burmese pythons are devastating the South Florida ecosystem by preying on small ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Abstract: Feature selection for high-risk disease diagnosis is critical for accurate risk assessment, yet existing methods fail to incorporate medical domain knowledge, potentially leading to ...

The United States could soon no longer be a country considered free of measles. The Pan American Health Organization, the part of the World Health Organization that tracks infectious disease in the ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

The South Florida Water Management District held a python hunt in December with cash prizes. Kevin Pavlidis won multiple awards, including for most pythons captured and the longest python. The ...

Wildlife experts in Florida continue to prioritize the elimination of invasive Burmese pythons. A presentation on the impact of pythons will be given by scientist Michael Kirkland on Sanibel Island.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...